Mark W. Hahn, Chief Financial Officer of Verona Pharma plc (VRNA), sold about 17.2 million dollars worth of company shares on the open market nine times over the past year. His most recent VRNA sale occurred on August 1, 2025. These transactions rank Hahn 754th among 11,678 insiders for total sales value, above the average of 8.6 million dollars per insider and 6 sales. Hahn made no open market purchases of VRNA stock in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 13, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Hahn Mark W | Not found | A | Common Stock | 10046 | $0.00 | 10,046.0000 | 54,921,916 | 9999.99% | 0.02% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 3285280 | $0.00 | 3,285,280.0000 | 727,223,000 | 9999.99% | 0.45% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | D | Ordinary Shares | 11264968 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 1.55% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | D | Ordinary Shares | 3285280 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.45% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 1649952 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.23% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Restricted Share Unit | 1649952 | $0.00 | 1,649,952.0000 | 727,223,000 | 9999.99% | 0.23% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 445536 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.06% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 389792 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.05% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 800000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.11% |
| Aug. 29, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | G | Ordinary Shares | 1200000 | $0.00 | 11,264,968.0000 | 727,223,000 | 9.63% | 0.17% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 208912 | $13.14 | 12,464,968.0000 | 727,223,000 | 1.65% | 0.03% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Stock Units | 200000 | $0.00 | 800,000.0000 | 727,223,000 | 20.00% | 0.03% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Stock Units | 55696 | $0.00 | 389,792.0000 | 727,223,000 | 12.50% | 0.01% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 255696 | $0.00 | 12,673,880.0000 | 727,223,000 | 2.06% | 0.04% |
| July 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Share Units | 229512 | $0.00 | 445,536.0000 | 727,223,000 | 34.00% | 0.03% |
| July 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 229512 | $0.00 | 12,508,504.0000 | 727,223,000 | 1.87% | 0.03% |
| July 8, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 90320 | $11.44 | 12,418,184.0000 | 727,223,000 | 0.72% | 0.01% |
| July 7, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Restricted Share Units | 675048 | $0.00 | 675,048.0000 | 727,223,000 | 9999.99% | 0.09% |
| June 11, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 400000 | $11.40 | 12,278,992.0000 | 652,311,000 | 3.15% | 0.06% |
| May 29, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 204864 | $9.33 | 12,678,992.0000 | 652,311,000 | 1.59% | 0.03% |
| May 28, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 162704 | $9.30 | 12,883,856.0000 | 652,311,000 | 1.25% | 0.02% |
| May 27, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 32432 | $9.53 | 13,046,560.0000 | 652,311,000 | 0.25% | 0.00% |
| May 2, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 400000 | $9.09 | 13,078,992.0000 | 652,311,000 | 2.97% | 0.06% |
| May 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 108272 | $8.95 | 13,357,728.0000 | 652,311,000 | 0.80% | 0.02% |
| May 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 200000 | $0.00 | 13,557,728.0000 | 652,311,000 | 1.50% | 0.03% |
| May 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 78736 | $8.95 | 13,478,992.0000 | 652,311,000 | 0.58% | 0.01% |
| May 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Share Units | 200000 | $0.00 | 1,000,000.0000 | 652,311,000 | 16.67% | 0.03% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 229512 | $0.00 | 13,556,360.0000 | 652,311,000 | 1.72% | 0.04% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 90360 | $8.98 | 13,466,000.0000 | 652,311,000 | 0.67% | 0.01% |
| Aug. 7, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Restricted Share Units | 1200000 | $0.00 | 1,200,000.0000 | 648,217,000 | 9999.99% | 0.19% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | M | Restricted Share Units | 229512 | $0.00 | 445,488.0000 | 652,311,000 | 34.00% | 0.04% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Restricted Share Units | 675000 | $0.00 | 675,000.0000 | 652,311,000 | 9999.99% | 0.10% |
| Feb. 3, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 166888 | $7.16 | 13,326,848.0000 | 652,311,000 | 1.24% | 0.03% |
| Feb. 1, 2025 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 200000 | $0.00 | 13,493,736.0000 | 652,311,000 | 1.50% | 0.03% |
| Dec. 4, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 58184 | $5.00 | 14,117,512.0000 | 648,217,000 | 0.41% | 0.01% |
| Dec. 5, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 640048 | $5.01 | 13,477,464.0000 | 648,217,000 | 4.53% | 0.10% |
| Dec. 6, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 183728 | $5.01 | 13,293,736.0000 | 648,217,000 | 1.36% | 0.03% |
| Dec. 2, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 1600 | $5.00 | 14,175,696.0000 | 648,217,000 | 0.01% | 0.00% |
| Nov. 27, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 12936 | $5.00 | 14,276,000.0000 | 648,217,000 | 0.09% | 0.00% |
| Nov. 29, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 98704 | $5.01 | 14,177,296.0000 | 648,217,000 | 0.69% | 0.02% |
| Nov. 26, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 800 | $5.00 | 14,288,936.0000 | 648,217,000 | 0.01% | 0.00% |
| Nov. 25, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 1600 | $5.00 | 14,289,736.0000 | 648,217,000 | 0.01% | 0.00% |
| Nov. 11, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 2400 | $5.00 | 14,291,336.0000 | 648,217,000 | 0.02% | 0.00% |
| Nov. 4, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 80784 | $4.39 | 14,293,736.0000 | 648,217,000 | 0.56% | 0.01% |
| Nov. 1, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 48888 | $4.38 | 14,374,520.0000 | 648,217,000 | 0.34% | 0.01% |
| Nov. 1, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 200000 | $0.00 | 14,669,360.0000 | 648,217,000 | 1.38% | 0.03% |
| Oct. 30, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 800000 | $0.00 | 14,469,360.0000 | 648,217,000 | 5.85% | 0.12% |
| Nov. 1, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 245952 | $4.24 | 14,423,408.0000 | 648,217,000 | 1.68% | 0.04% |
| Oct. 25, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 3200 | $4.38 | 13,669,360.0000 | 648,217,000 | 0.02% | 0.00% |
| Oct. 24, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 141360 | $4.38 | 13,672,560.0000 | 648,217,000 | 1.02% | 0.02% |
| Oct. 22, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 159344 | $4.38 | 13,813,920.0000 | 648,217,000 | 1.14% | 0.02% |
| Oct. 21, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 116696 | $4.38 | 13,973,264.0000 | 648,217,000 | 0.83% | 0.02% |
| Oct. 18, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 249728 | $4.38 | 14,089,960.0000 | 648,217,000 | 1.74% | 0.04% |
| Sept. 11, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 600000 | $3.76 | 14,339,688.0000 | 648,217,000 | 4.02% | 0.09% |
| Aug. 12, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 1600 | $3.13 | 15,338,088.0000 | 648,217,000 | 0.01% | 0.00% |
| Aug. 13, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 3736 | $3.25 | 14,939,688.0000 | 648,217,000 | 0.03% | 0.00% |
| Aug. 13, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 394664 | $3.20 | 14,943,424.0000 | 648,217,000 | 2.57% | 0.06% |
| Aug. 7, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 314800 | $2.62 | 15,339,688.0000 | 648,217,000 | 2.01% | 0.05% |
| Aug. 7, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 800000 | $0.00 | 15,654,488.0000 | 648,217,000 | 5.39% | 0.12% |
| Aug. 1, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 88544 | $2.83 | 14,854,488.0000 | 648,217,000 | 0.59% | 0.01% |
| May 1, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 88544 | $1.93 | 14,943,032.0000 | 634,143,000 | 0.59% | 0.01% |
| Feb. 1, 2024 | Verona Pharma plc | $VRNA | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 480664 | $2.29 | 15,031,576.0000 | 634,143,000 | 3.10% | 0.08% |